Cassava Sciences | PTIE - Market Capitalization


Cassava Sciences reported $38.5M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Cara Therapeutics USD 30M 336M Mar/2026
Cassava Sciences USD 82M 14M Mar/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026